Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04566263 · ClinicalTrials.gov registry record · NA

Treatment of Intracranial Wide-neck Aneurysms Using Stent-assisted Coil Embolization

A NA study of Intracranial Aneurysms, sponsored by Methodist Health System.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04566263 is a NA study of Intracranial Aneurysms that has completed, run by Methodist Health System. The registered enrollment target is 30 participants, below the 43-participant average among 4 other Intracranial Aneurysms trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04566263, a NA study of Intracranial Aneurysms, has completed, sponsored by Methodist Health System.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This device was designed to assist in the stent-assisted coil embolization of intracranial aneurysms, specifically those that have a wide neck that would not otherwise maintain the coil embolization material within the aneurysm because of the wide opening at the base of the aneurysm. This device was designed to treat aneurysms that are: unruptured, wide-necked, intracranial, saccular aneurysms arising from a parent vessel ≥ 2 mm and ≤ 4.5 mm. Wide-necked was defined as having a neck \> 4mm or dome-to-neck ratio \< 2.

Conditions Studied

Interventions

  • DEVICE Neuroform EZ Stent System

Study Locations (1)

Texas

  • Methodist Dallas Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-02-28
Est. Completion 2021-01-07
Phase NA

Sponsor

Methodist Health System

125 total trials

What the Registry Record Tells You About NCT04566263

The ClinicalTrials.gov registry entry for NCT04566263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 43-participant average among 4 other Intracranial Aneurysms trials with a reported enrollment target (30% lower). The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracranial Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which Neuroform EZ Stent System is the first listed.

NCT04566263 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04566263 about?

NCT04566263 is a clinical study titled "Treatment of Intracranial Wide-neck Aneurysms Using Stent-assisted Coil Embolization". This device was designed to assist in the stent-assisted coil embolization of intracranial aneurysms, specifically those that have a wide neck that would not otherwise maintain the coil embolization material within the aneurysm because of the wide opening at the base of the aneurysm. This device was...

What is the current status of trial NCT04566263?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-02-28. Estimated completion is 2021-01-07.

What conditions does trial NCT04566263 study?

This clinical trial studies the following conditions: Intracranial Aneurysms.

What interventions are being tested in trial NCT04566263?

The interventions under investigation include: Neuroform EZ Stent System (DEVICE).

Who is sponsoring clinical trial NCT04566263?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04566263 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracranial Aneurysms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.